Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Nutex Health Inc. (NUTX) Institutional Ownership & Insider Trading

154 institutions reported holding Nutex Health Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 6 insider trades on Form 4 since 2025-10-01.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

NUTXNutex Health Inc.Follow NUTX — free
Medical Care Facilities · Healthcare
—
Price chart with a free account
Market cap
1.4B
P/E TTM
8.2
Dividend yield
—
52-week
—
Next earnings
17 Nov, in 24 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

154 institutions held 42.9% of the shares. Across filers that reported both quarters, shares held changed +4.5%.

Increased+60New+33Decreased-33Closed-9

Largest moves, shares (millions)

D. E. Shaw+0.1MPertento Partners+0.1MFocus Partners Wealth+0.1MTopline Capital Management-0.1MMillennium Management-0.0MDrive Wealth Management-0.0M

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters
+0.0Sep 24+0.3Dec 24+0.1Mar 25+0.7Jun 25+0.7Sep 25+0.2Dec 25+0.1Mar 26+0.1Jun 26
QuarterHoldersShares held, MChangeIncreasedNewDecreasedClosed
Jun 261543+4.5%6033339
Mar 261273+5.0%50302320
Dec 251153+8.0%3125319
Sep 25942+39.6%35281134
Jun 251002+72.1%1761176
Mar 25461+11.8%159134
Dec 24411+56.4%91483
Sep 24260—————

Nutex Health Inc. — questions

Who owns Nutex Health Inc. stock?
154 institutions reported Nutex Health Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: Pertento Partners LLP (6.6%), BlackRock, Inc. (6.0%), AMERICAN CENTURY COMPANIES INC (3.5%).
Are Nutex Health Inc. insiders buying or selling?
6 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.

Every figure on this page comes from Nutex Health Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.